menu ☰
menu ˟

Polymyxin B hemoperfusion fails to improve survival in septic shock

10 Oct 2018
Polymyxin B hemoperfusion treatment plus conventional medical therapy was not effective in reducing mortality at 28 days among patients with septic shock and high endotoxin activity, according to research published in JAMA.“Polymyxin B hemoperfusio...

Click here to view the full article which appeared in Infectious Disease

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.